Discover open access scientific publications

Search, annotate, share and cite publications

Publications by P Lahdenne

PReS-FINAL-2002: Adverse Events During Anti-TNF Therapy in Patients With JIA

Pediatric Rheumatology

English

Molecular Characterization of a 6.6-Kilodalton Borrelia Burgdorferi Outer Membrane-Associated Lipoprotein (Lp6.6) Which Appears to Be Downregulated During Mammalian Infection.

Infection and Immunity

English

Related publications

Review Article: Managing the Adverse Events Caused by Anti-TNF Therapy in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics

English

PReS-FINAL-2058: Lipid Peroxides, Lipophuscin, Sulfhydryl Groups and TOS in Children With JIA

Pediatric Rheumatology

English

Original Paper Autoimmunogenicity During Anti-TNF Therapy in Patients With Psoriasis and Psoriatic Arthritis

Postepy Dermatologii I Alergologii

English

PReS-FINAL-2240: Serum Amyloid Protein a Concentration in CAPS Patients Treated With Anti IL1Β

Pediatric Rheumatology

English

PReS-FINAL-2108: Long-Term Outcome of 114 Adult JIA Patients in a Non-Pediatric Rheumatology Institute in Japan

Pediatric Rheumatology

English

PReS-FINAL-1005: Hypertransaminasemia in Systemic Juvenile Idiopathic Arthritis During Anti-Interleukin 1 Treatment

Pediatric Rheumatology

English

Association Between Immune-Related Adverse Events During Anti–PD-1 Therapy and Tumor Mutational Burden

English

PReS-FINAL-2029: Long-Term Follow-Up of Patients With Juvenile Idiopathic Arthritis (JIA) in a Single Center: A Systematic Chart Review

Pediatric Rheumatology

English

632 Cutaneous Immune-Related Adverse Events in 1,857 Patients Treated With Anti-Pd-1 Therapy at an Academic Center

Journal of Investigative Dermatology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by P Lahdenne

PReS-FINAL-2002: Adverse Events During Anti-TNF Therapy in Patients With JIA

Molecular Characterization of a 6.6-Kilodalton Borrelia Burgdorferi Outer Membrane-Associated Lipoprotein (Lp6.6) Which Appears to Be Downregulated During Mammalian Infection.

Related publications

Review Article: Managing the Adverse Events Caused by Anti-TNF Therapy in Inflammatory Bowel Disease

PReS-FINAL-2058: Lipid Peroxides, Lipophuscin, Sulfhydryl Groups and TOS in Children With JIA

Original Paper Autoimmunogenicity During Anti-TNF Therapy in Patients With Psoriasis and Psoriatic Arthritis

PReS-FINAL-2240: Serum Amyloid Protein a Concentration in CAPS Patients Treated With Anti IL1Β

PReS-FINAL-2108: Long-Term Outcome of 114 Adult JIA Patients in a Non-Pediatric Rheumatology Institute in Japan

PReS-FINAL-1005: Hypertransaminasemia in Systemic Juvenile Idiopathic Arthritis During Anti-Interleukin 1 Treatment

Association Between Immune-Related Adverse Events During Anti–PD-1 Therapy and Tumor Mutational Burden

PReS-FINAL-2029: Long-Term Follow-Up of Patients With Juvenile Idiopathic Arthritis (JIA) in a Single Center: A Systematic Chart Review

632 Cutaneous Immune-Related Adverse Events in 1,857 Patients Treated With Anti-Pd-1 Therapy at an Academic Center